{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:35Z","timestamp":1792788515065,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173508"],"award-info":[{"award-number":["82173508"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nutrilite Plant Functional Components and Health Research Fund of Chinese Nutrition Society","award":["CNS-NCL2024-04"],"award-info":[{"award-number":["CNS-NCL2024-04"]}],"id":[{"id":"https:\/\/ror.org\/00yg6a139","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation","award":["QY25427"],"award-info":[{"award-number":["QY25427"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is an irreversible neurodegenerative disorder lacking curative therapies, with ApoE4 as the strongest genetic risk factor driving lipid dyshomeostasis and neuronal damage in the central nervous system. Lipid rafts, cholesterol- and sphingolipid-rich membrane microdomains, govern key neuronal signalling, and dysfunction of these microdomains mediates the progression of preclinical pathological lesions in ApoE4 carriers. Dietary docosahexaenoic acid (DHA) is widely reported to mitigate brain lipid disorders, yet how DHA remodels subfractions of lipid raft and non-raft membrane domains to rescue ApoE4-related energy metabolism disorder remains unclear. Most existing studies have only quantified total brain lipids without distinguishing membrane subdomains, and few characterized the liver-brain metabolic axis underlying ApoE4-associated neurodegeneration. We constructed female ApoE3\/3 and ApoE4\/4 knock-in mice with 6- and 12-month DHA dietary interventions, combining behavioral, histological, lipidomic and proteomic assays to characterize genotype-specific lipid remodelling and downstream mitochondrial changes. Here we show that ApoE4 mice develop severe hepatic steatosis, neuroinflammation and lipid raft rigidification characterized by elevated sulfatides and ceramides levels, DHA upregulates\n                    <jats:italic>Lpin1<\/jats:italic>\n                    ,\n                    <jats:italic>Atgl<\/jats:italic>\n                    and\n                    <jats:italic>nSMase2<\/jats:italic>\n                    while suppressing\n                    <jats:italic>Acer3<\/jats:italic>\n                    and\n                    <jats:italic>Sgms2<\/jats:italic>\n                    , thereby rebalancing lipids raft and restoring mitochondrial bioenergetics. Our work resolves raft and non-raft lipid profiles in ApoE humanized mice, and links peripheral hepatic metabolic disturbances to cerebral membrane microdomain dysfunction. These multi-omics mechanistic findings advance genotype-specific preventive nutritional strategies for ApoE4 carriers and reveal potential subcellular lipid targets for early AD intervention.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00618-x","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:08:47Z","timestamp":1792073327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Docosahexaenoic acid remodels lipid composition of lipid rafts and mitochondrial function in ApoE4\/4 mouse brain: a multi-omic investigation"],"prefix":"10.1186","volume":"7","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"23","key":"618_CR1","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1016\/j.scib.2024.09.042","volume":"69","author":"J Shi","year":"2024","unstructured":"Shi J, Touchon J, Middleton L, Rovira M, Vassar R, Vellas B, et al. Now and future: strategies for diagnosis, prevention and therapies for Alzheimer\u2019s disease. Sci Bull. 2024;69(23):3777\u201384. https:\/\/doi.org\/10.1016\/j.scib.2024.09.042.","journal-title":"Sci Bull"},{"issue":"1","key":"618_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"618_CR3","doi-asserted-by":"publisher","first-page":"afae005","DOI":"10.1093\/ageing\/afae005","volume":"53","author":"H Dolphin","year":"2024","unstructured":"Dolphin H, Dyer A, Morrison L, Shenkin S, Welsh T, Kennelly S. New horizons in the diagnosis and management of Alzheimer\u2019s disease in older adults. Age Ageing. 2024;53(2):afae005. https:\/\/doi.org\/10.1093\/ageing\/afae005.","journal-title":"Age Ageing"},{"issue":"10284","key":"618_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen C, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4.","journal-title":"Lancet"},{"issue":"1","key":"618_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/s1474-4422(20)30412-9","volume":"20","author":"A Serrano","year":"2021","unstructured":"Serrano A, Das S, Hyman B. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20(1):68\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(20)30412-9.","journal-title":"Lancet Neurol"},{"issue":"9","key":"618_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield T, Liu C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318. https:\/\/doi.org\/10.1038\/s41582-019-0228-7.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"618_CR7","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1194\/jlr.R075630","volume":"58","author":"T Chang","year":"2017","unstructured":"Chang T, Yamauchi Y, Hasan M, Chang C. Cellular cholesterol homeostasis and Alzheimer\u2019s disease. J Lipid Res. 2017;58(12):2239\u201354. https:\/\/doi.org\/10.1194\/jlr.R075630.","journal-title":"J Lipid Res"},{"issue":"1\u20132","key":"618_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0163-7827(00)00017-5","volume":"40","author":"L Lauritzen","year":"2001","unstructured":"Lauritzen L, Hansen H, J\u00f8rgensen M, Michaelsen K. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001;40(1\u20132):1\u201394. https:\/\/doi.org\/10.1016\/s0163-7827(00)00017-5.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"618_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/nu15010161","volume":"15","author":"A Sinclair","year":"2022","unstructured":"Sinclair A, Wang Y, Li D. What is the evidence for dietary-induced DHA deficiency in human brains? Nutrients. 2022;15(1):161. https:\/\/doi.org\/10.3390\/nu15010161.","journal-title":"Nutrients"},{"issue":"10","key":"618_CR10","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.3390\/ijms23105390","volume":"23","author":"A Petermann","year":"2022","unstructured":"Petermann A, Reyna M, Ortega L, Coddou C, Y\u00e9venes G. Roles of the Unsaturated Fatty Acid Docosahexaenoic Acid in the Central Nervous System: Molecular and Cellular Insights. Int J Mol Sci. 2022;23(10):5390. https:\/\/doi.org\/10.3390\/ijms23105390.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"618_CR11","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/j.ejphar.2011.05.085","volume":"668","author":"P Calder","year":"2011","unstructured":"Calder P. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol. 2011;668(Suppl 1):S50\u20138. https:\/\/doi.org\/10.1016\/j.ejphar.2011.05.085.","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"618_CR12","doi-asserted-by":"publisher","first-page":"11321","DOI":"10.1073\/pnas.1734008100","volume":"100","author":"G Barcel\u00f3","year":"2003","unstructured":"Barcel\u00f3 G, H\u00f6gyes E, Kitajka K, Pusk\u00e1s L, Zvara A, Hackler L, et al. Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci USA. 2003;100(20):11321\u20136. https:\/\/doi.org\/10.1073\/pnas.1734008100.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"618_CR13","doi-asserted-by":"publisher","first-page":"11847","DOI":"10.3390\/ijms222111847","volume":"22","author":"A Jurcau","year":"2021","unstructured":"Jurcau A. Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress. Int J Mol Sci. 2021;22(21):11847. https:\/\/doi.org\/10.3390\/ijms222111847.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"618_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/35036052","volume":"1","author":"K Simons","year":"2000","unstructured":"Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1(1):31\u20139. https:\/\/doi.org\/10.1038\/35036052.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-511x-8-33","volume":"8","author":"B Anderson","year":"2009","unstructured":"Anderson B, Ma D. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 2009;8:33. https:\/\/doi.org\/10.1186\/1476-511x-8-33.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"618_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1172\/jci16390","volume":"110","author":"K Simons","year":"2002","unstructured":"Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. 2002;110(5):597\u2013603. https:\/\/doi.org\/10.1172\/jci16390.","journal-title":"J Clin Invest"},{"issue":"10","key":"618_CR17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/NEN.0b013e31826be03c","volume":"71","author":"N Fabelo","year":"2012","unstructured":"Fabelo N, Mart\u00edn V, Mar\u00edn R, Santpere G, Aso E, Ferrer I, et al. Evidence for premature lipid raft aging in APP\/PS1 double-transgenic mice, a model of familial Alzheimer disease. J Neuropathol Exp Neurol. 2012;71(10):868\u201381. https:\/\/doi.org\/10.1097\/NEN.0b013e31826be03c.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"618_CR18","doi-asserted-by":"publisher","first-page":"e13867","DOI":"10.1111\/acel.13867","volume":"22","author":"M D\u00edaz","year":"2023","unstructured":"D\u00edaz M, Pereda D, Vald\u00e9 C, Santos G, Marin R. Molecular and biophysical features of hippocampal \u201clipid rafts aging\u201d are modified by dietary n-3 long-chain polyunsaturated fatty acids. Aging Cell. 2023;22(8):e13867. https:\/\/doi.org\/10.1111\/acel.13867.","journal-title":"Aging Cell"},{"issue":"4","key":"618_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann A, Tian L, Henderson V, Greicius M, Alzheimer\u2019s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75(4):563\u201373. https:\/\/doi.org\/10.1002\/ana.24135.","journal-title":"Ann Neurol"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"1279343","DOI":"10.3389\/fnagi.2023.1279343","volume":"15","author":"D Balu","year":"2023","unstructured":"Balu D, Valencia A, Islam Z, Mielczarek C, Hansen A, Perez T, et al. APOE genotype and sex modulate Alzheimer\u2019s disease pathology in aged EFAD transgenic mice. Front Aging Neurosci. 2023;15:1279343. https:\/\/doi.org\/10.3389\/fnagi.2023.1279343.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"618_CR21","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1096\/fj.201900423R","volume":"33","author":"A Martinsen","year":"2019","unstructured":"Martinsen A, Tejera N, Vauzour D, Harden G, Dick J, Shinde S, et al. Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice. FASEB J. 2019;33(9):10315\u201326. https:\/\/doi.org\/10.1096\/fj.201900423R.","journal-title":"FASEB J"},{"issue":"4","key":"618_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/pathophysiology31040040","volume":"31","author":"A Laslo","year":"2024","unstructured":"Laslo A, Laslo L, Arb\u0103na\u0219i E, Ujlaki A, Chinezu L, Iv\u0103nescu A, et al. Pathways to Alzheimer\u2019s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-\u03b2 Regulation and Neuronal Health. Pathophysiology. 2024;31(4):545\u201358. https:\/\/doi.org\/10.3390\/pathophysiology31040040.","journal-title":"Pathophysiology"},{"issue":"1","key":"618_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.14336\/ad.2023.0530","volume":"15","author":"P Huebbe","year":"2024","unstructured":"Huebbe P, Bilke S, Rueter J, Schloesser A, Campbel G, Gl\u00fcer C, et al. Human APOE4 protects high-fat and high-sucrose diet fed targeted replacement mice against fatty liver disease compared to APOE3. Aging Dis. 2024;15(1):259\u201381. https:\/\/doi.org\/10.14336\/ad.2023.0530.","journal-title":"Aging Dis"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"112329","DOI":"10.1016\/j.biopha.2021.112329","volume":"144","author":"J Xu","year":"2021","unstructured":"Xu J, Guo Y, Huang X, Ma X, Li P, Wang Y, et al. Effects of DHA dietary intervention on hepatic lipid metabolism in apolipoprotein E-deficient and C57BL\/6J wild-type mice. Biomed Pharmacother. 2021;144:112329. https:\/\/doi.org\/10.1016\/j.biopha.2021.112329.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"618_CR25","doi-asserted-by":"publisher","first-page":"e53569","DOI":"10.1371\/journal.pone.0053569","volume":"7","author":"L Leung","year":"2012","unstructured":"Leung L, Andrews Y, Yoon S, Jain S, Ring K, Dai J, et al. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLoS ONE. 2012;7(12):e53569. https:\/\/doi.org\/10.1371\/journal.pone.0053569.","journal-title":"PLoS ONE"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"1579411","DOI":"10.3389\/fnagi.2025.1579411","volume":"17","author":"Y Park","year":"2025","unstructured":"Park Y, Moon S, Jung H, Park S, Kim J, Song D, et al. Mirodenafil improves cognitive function by reducing microglial activation and blood-brain barrier permeability in ApoE4 KI mice. Front Aging Neurosci. 2025;17:1579411. https:\/\/doi.org\/10.3389\/fnagi.2025.1579411.","journal-title":"Front Aging Neurosci"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.nbas.2022.100046","volume":"2","author":"H Chappus","year":"2022","unstructured":"Chappus H, Poulin M, Chouinard R, Vandal M, Calon F, Lauzon M, et al. A diet rich in docosahexaenoic acid enhances reactive astrogliosis and ramified microglia morphology in apolipoprotein E epsilon 4-targeted replacement mice. Aging Brain. 2022;2:100046. https:\/\/doi.org\/10.1016\/j.nbas.2022.100046.","journal-title":"Aging Brain"},{"issue":"5","key":"618_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1042\/bst20160474","volume":"45","author":"P Calder","year":"2017","unstructured":"Calder P. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105\u201315. https:\/\/doi.org\/10.1042\/bst20160474.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"618_CR29","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1471-4159.2007.04810.x","volume":"103","author":"O Levi","year":"2007","unstructured":"Levi O, Dolev I, Belinson H, Michaelson D. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation. J Neurochem. 2007;103(3):1031\u201340. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04810.x.","journal-title":"J Neurochem"},{"issue":"7","key":"618_CR30","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s00259-021-05192-8","volume":"48","author":"G Salvad\u00f3","year":"2021","unstructured":"Salvad\u00f3 G, Grothe M, Groot C, Moscoso A, Sch\u00f6ll M, Gispert J, et al. Differential associations of APOE-\u03b52 and APOE-\u03b54 alleles with PET-measured amyloid-\u03b2 and tau deposition in older individuals without dementia. Eur J Nucl Med Mol Imaging. 2021;48(7):2212\u201324. https:\/\/doi.org\/10.1007\/s00259-021-05192-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"618_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1471-4159.2009.06336.x","volume":"111","author":"S Hossain","year":"2009","unstructured":"Hossain S, Hashimoto M, Katakura M, Miwa K, Shimada T, Shido O. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells. J Neurochem. 2009;111(2):568\u201379. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06336.x.","journal-title":"J Neurochem"},{"key":"618_CR32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.nbd.2015.09.002","volume":"82","author":"E Teng","year":"2015","unstructured":"Teng E, Taylor K, Bilousova T, Weiland D, Pham T, Zuo X, et al. Dietary DHA supplementation in an APP\/PS1 transgenic rat model of AD reduces behavioral and A\u03b2 pathology and modulates A\u03b2 oligomerization. Neurobiol Dis. 2015;82:552\u201360. https:\/\/doi.org\/10.1016\/j.nbd.2015.09.002.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"618_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-022-00590-4","volume":"18","author":"C Young","year":"2023","unstructured":"Young C, Johns E, Kennedy G, Belloy M, Insel P, Greicius M, et al. APOE effects on regional tau in preclinical Alzheimer\u2019s disease. Mol Neurodegener. 2023;18(1):1. https:\/\/doi.org\/10.1186\/s13024-022-00590-4.","journal-title":"Mol Neurodegener"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"111105","DOI":"10.1016\/j.pnpbp.2024.111105","volume":"135","author":"L Xia","year":"2024","unstructured":"Xia L, Li J, Pang Y, Xu M, Du Y, Chen M, et al. Dihydroartemisinin promotes tau O-GlcNAcylation and improves cognitive function in hTau transgenic mice. Prog Neuropsychopharmacol Biol Psychiatry. 2024;135:111105. https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111105.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"16","key":"618_CR35","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","volume":"27","author":"K Green","year":"2007","unstructured":"Green K, Martinez H, Khashwji H, Hall E, Yurko K, Ellis L, et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci. 2007;27(16):4385\u201395. https:\/\/doi.org\/10.1523\/JNEUROSCI.0055-07.2007.","journal-title":"J Neurosci"},{"issue":"4","key":"618_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tem.2021.01.006","volume":"32","author":"M Falabella","year":"2021","unstructured":"Falabella M, Vernon H, Hanna M, Claypool S, Pitceathly R. Cardiolipin, Mitochondria, and Neurological Disease. Trends Endocrinol Metab. 2021;32(4):224\u201337. https:\/\/doi.org\/10.1016\/j.tem.2021.01.006.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"618_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/cells8070728","volume":"8","author":"G Paradies","year":"2019","unstructured":"Paradies G, Paradies V, Ruggiero F, Petrosillo G. Role of cardiolipin in mitochondrial function and dynamics in health and disease: molecular and pharmacological aspects. Cells. 2019;8(7):728. https:\/\/doi.org\/10.3390\/cells8070728.","journal-title":"Cells"},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.fct.2018.01.017","volume":"113","author":"S Kaddah","year":"2018","unstructured":"Kaddah S, Khreich N, Kaddah F, Charcosset C, Greige H. Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food Chem Toxicol. 2018;113:40\u20138. https:\/\/doi.org\/10.1016\/j.fct.2018.01.017.","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"618_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"T Harayama","year":"2018","unstructured":"Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol. 2018;19(5):281\u201396. https:\/\/doi.org\/10.1038\/nrm.2017.138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"618_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fphys.2012.00454","volume":"3","author":"M Diaz","year":"2012","unstructured":"Diaz M, Fabelo N, Mar\u00edn R. Genotype-induced changes in biophysical properties of frontal cortex lipid raft from APP\/PS1 transgenic mice. Front Physiol. 2012;3:454. https:\/\/doi.org\/10.3389\/fphys.2012.00454.","journal-title":"Front Physiol"},{"key":"618_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.trci.2019.08.003","volume":"5","author":"V Senanayake","year":"2019","unstructured":"Senanayake V, Goodenowe D. Plasmalogen deficiency and neuropathology in Alzheimer\u2019s disease: Causation or coincidence? Alzheimers Dement (N Y). 2019;5:524\u201332. https:\/\/doi.org\/10.1016\/j.trci.2019.08.003.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"19","key":"618_CR42","doi-asserted-by":"publisher","first-page":"10745","DOI":"10.3390\/ijms251910745","volume":"25","author":"J Korbecki","year":"2024","unstructured":"Korbecki J, Bosiacki M, Kupnicka P, Barczak K, Zi\u0119tek P, Chlubek D, et al. Biochemistry and diseases related to the interconversion of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine. Int J Mol Sci. 2024;25(19):10745. https:\/\/doi.org\/10.3390\/ijms251910745.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"618_CR43","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K, J\u0119\u015bko H, Wencel P, Lukiw W, Strosznajder R. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer\u2019s Disease and Other Neurodegenerative Disorders. Mol Neurobiol. 2019;56(8):5436\u201355. https:\/\/doi.org\/10.1007\/s12035-018-1448-3.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"618_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40035-023-00383-9","volume":"12","author":"C Tallon","year":"2023","unstructured":"Tallon C, Bell B, Malvankar M, Deme P, Nogueras C, et al. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer\u2019s disease mouse model. Transl Neurodegener. 2023;12(1):56. https:\/\/doi.org\/10.1186\/s40035-023-00383-9.","journal-title":"Transl Neurodegener"},{"key":"618_CR45","doi-asserted-by":"publisher","first-page":"114796","DOI":"10.1016\/j.bcp.2021.114796","volume":"194","author":"C Tallon","year":"2021","unstructured":"Tallon C, Picciolini S, Yoo S, Thomas A, Pal A, Alt J, et al. Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury. Biochem Pharmacol. 2021;194:114796. https:\/\/doi.org\/10.1016\/j.bcp.2021.114796.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"618_CR46","doi-asserted-by":"publisher","first-page":"e12855","DOI":"10.1111\/nan.12855","volume":"49","author":"J Xu","year":"2023","unstructured":"Xu J, Huang X, Guo Y, Ma X, Li P, Zhou S, et al. Discrepant modulating effects of dietary docosahexaenoic acid on cerebral lipids, fatty acid transporter expression and soluble beta-amyloid levels in ApoE(-\/-) and C57BL\/6J mice. Neuropathol Appl Neurobiol. 2023;49(1):e12855. https:\/\/doi.org\/10.1111\/nan.12855.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"618_CR47","doi-asserted-by":"publisher","first-page":"0006","DOI":"10.34133\/research.0006","volume":"2022","author":"H Miao","year":"2022","unstructured":"Miao H, Li B, Wang Z, Mu J, Tian Y, Jiang B, et al. Lipidome Atlas of the Developing Heart Uncovers Dynamic Membrane Lipid Attributes Underlying Cardiac Structural and Metabolic Maturation. Research. 2022;2022:0006. https:\/\/doi.org\/10.34133\/research.0006.","journal-title":"Research"},{"issue":"7","key":"618_CR48","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s42255-021-00425-4","volume":"3","author":"S Lam","year":"2021","unstructured":"Lam S, Zhang C, Wang Z, Ni Z, Zhang S, Yang S, et al. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab. 2021;3(7):909\u201322. https:\/\/doi.org\/10.1038\/s42255-021-00425-4.","journal-title":"Nat Metab"},{"issue":"6","key":"618_CR49","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1039\/b913353d","volume":"6","author":"G Shui","year":"2010","unstructured":"Shui G, Guan X, Low C, Chua G, Goh J, Yang H, et al. Toward one step analysis of cellular lipidomes using liquid chromatography coupled with mass spectrometry: application to Saccharomyces cerevisiae and Schizosaccharomyces pombe lipidomics. Mol Biosyst. 2010;6(6):1008\u201317. https:\/\/doi.org\/10.1039\/b913353d.","journal-title":"Mol Biosyst"},{"issue":"28","key":"618_CR50","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1016\/j.chroma.2011.05.011","volume":"1218","author":"G Shui","year":"2011","unstructured":"Shui G, Cheong W, Jappar I, Hoi A, Xue Y, Fernandis A, et al. Derivatization-independent cholesterol analysis in crude lipid extracts by liquid chromatography\/mass spectrometry: applications to a rabbit model for atherosclerosis. J Chromatogr A. 2011;1218(28):4357\u201365. https:\/\/doi.org\/10.1016\/j.chroma.2011.05.011.","journal-title":"J Chromatogr A"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00618-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:08:48Z","timestamp":1792073328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00618-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00618-x","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Regulations for Administration of Affairs Concerning Experimental Animals guidelines and approved protocols of Capital Medical University (AEEI-2019\u2013008).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All author declared no conflict of interest. All author has no potential COI related to company employment, editorial board of this journal, patents, etc.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"212"}}